CAS: 1607837-31-9
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
CCT-251921 REF: 3D-HPC83731CAS: 1607837-31-9 | Min. 95% | A consultar | Mar 21 Ene 25 | |
CCT-251921 REF: TM-T14901CAS: 1607837-31-9 | 97.74% | 94,00 €~1.049,00 € | Mar 11 Feb 25 |
CCT-251921
CAS:1607837-31-9
CCT-251921 is a molecule that inhibits the activity of cyclin-dependent kinases (CDKs) 4 and 6. …
Fórmula:
C21H23ClN6O
Pureza:
Min. 95%
Peso molecular:
410.9 g/mol
Ref: 3D-HPC83731
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
CCT-251921
CAS:1607837-31-9
CCT-251921 is a potent, selective, and orally bioavailable CDK8 inhibitor (IC50: 2.3 nM).
Fórmula:
C21H23ClN6O
Pureza:
97.74%
Forma y color:
Solid
Peso molecular:
410.9
Ref: TM-T14901
1mg | 94,00 € | ||
5mg | 218,00 € | ||
10mg | 318,00 € | ||
25mg | 536,00 € | ||
50mg | 768,00 € | ||
100mg | 1.049,00 € | ||
1mL*10mM (DMSO) | 201,00 € |
Entrega estimada en Estados Unidos, el Martes 11 de Febrero de 2025